Sex-specific programming of hypertension in offspring of late-gestation diabetic rats

Pediatric Research

Volumn 72, Issue 4, 2012, Pages 352-361

  Katkhuda, Ragheed ^a   Peterson, Emily S ^a   Roghair, Robert D ^a   Norris, Andrew W ^a   Scholz, Thomas D ^a   Segar, Jeffrey L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIETHYLDITHIOCARBAMIC ACID; GANGLION BLOCKING AGENT; INSULIN; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GANGLION BLOCK; HEMODYNAMICS; HYPERGLYCEMIA; HYPERTENSION; IN VIVO STUDY; INSULIN TREATMENT; MALE; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGENY; RAT; SEX DIFFERENCE; STREPTOZOCIN DIABETES; THIRD TRIMESTER PREGNANCY; TREATMENT RESPONSE;

AGE FACTORS; ANGIOTENSIN II; ANIMALS; BAROREFLEX; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES, GESTATIONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GANGLIONIC BLOCKERS; GESTATIONAL AGE; HEART RATE; HYPERTENSION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOTYPE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SIGNAL TRANSDUCTION; STREPTOZOCIN; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84867047874     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.93     Document Type: Article

References (45)

1. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28:579-84.
2. Shaw J. Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes 2007;8:Suppl 9:7-15.
3. Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin North Am 2004;51:619-37, viii.
4. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007;30:Suppl 2:S169-74.
5. Lee H, Jang HC, Park HK, Cho NH. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus. Diabetes Res Clin Pract 2007;78: 238-45.
6. Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 2002;45:991-6.
7. Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 2007;50: 972-9.
8. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008;21:149-57.
9. Bunt JC, Tataranni PA, Salbe AD. Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children. J Clin Endocrinol Metab 2005;90:3225-9.
10. Cho NH, Silverman BL, Rizzo TA, Metzger BE. Correlations between the intrauterine metabolic environment and blood pressure in adolescent offspring of diabetic mothers. J Pediatr 2000;136:587-92.
11. Mansford KR, Opie L. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1968;1:670-1.
12. Holemans K, Gerber RT, Meurrens K, De Clerck F, Poston L, Van Assche FA. Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 1999;42:81-9.
13. Rocha SO, Gomes GN, Forti AL, et al. Long-term effects of maternal diabetes on vascular reactivity and renal function in rat male offspring. Pediatr Res 2005;58:1274-9.
14. Wichi RB, Souza SB, Casarini DE, Morris M, Barreto-Chaves ML, Irigoyen MC. Increased blood pressure in the offspring of diabetic mothers. Am J Physiol Regul Integr Comp Physiol 2005;288:R1129-33.
15. Duong Van Huyen JP, Vessies E, Perret C, et al. In utero exposure to maternal diabetes impairs vascular expression of prostacyclin receptor in rat offspring. Diabetes 2010;59:2597-602.
16. Gomes GN, Gil FZ. Prenatally programmed hypertension: role of maternal diabetes. Braz J Med Biol Res 2011;44:899-904.
17. Segar EM, Norris AW, Yao JR, et al. Programming of growth, insulin resistance and vascular dysfunction in offspring of late gestation diabetic rats. Clin Sci 2009;117:129-38.
18. Gordon FJ, Matsuguchi H, Mark AL. Abnormal baroreflex control of heart rate in prehypertensive and hypertensive Dahl genetically salt-sensitive rats. Hypertension 1981;3(3 Pt 2):I135-41.
19. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 2006;27:327-32.
20. Grissa O, Atbo JM, Yessoufou A, et al. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl Res 2007;150:164-71.
21. Alexander BT. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 2003;41:457-62.
22. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001;49:460-7.
23. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int 2004;65:1339-48.
24. Gilbert JS, Nijland MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol 2008;295:R1941-52.
25. Lohmeier TE. The sympathetic nervous system and long-term blood pressure regulation. Am J Hypertens 2001;14(6 Pt 2):147S-54S.
26. Cavanal Mde F, Gomes GN, Forti AL, et al. The influence of L-arginine on blood pressure, vascular nitric oxide and renal morphometry in the offspring from diabetic mothers. Pediatr Res 2007;62:145-50.
27. MohanKumar SM, King A, Shin AC, Sirivelu MP, MohanKumar PS, Fink GD. Developmental programming of cardiovascular disorders: focus on hypertension. Rev Endocr Metab Disord 2007;8:115-25.
28. Nuyt AM, Alexander BT. Developmental programming and hypertension. Curr Opin Nephrol Hypertens 2009;18:144-52.
29. Segar JL, Roghair RD, Segar EM, Bailey MC, Scholz TD, Lamb FS. Early gestation dexamethasone alters baroreflex and vascular responses in newborn lambs before hypertension. Am J Physiol Regul Integr Comp Physiol 2006;291:R481-8.
30. Nehiri T, Duong Van Huyen JP, Viltard M, et al. Exposure to maternal diabetes induces salt-sensitive hypertension and impairs renal function in adult rat offspring. Diabetes 2008;57:2167-75.
31. Kinalski M, Sledziewski A, Telejko B, Zarzycki W, Kinalska I. Antioxidant therapy and streptozotocin-induced diabetes in pregnant rats. Acta Diabetol 1999;36:113-7.
32. Raza H, John A. Glutathione metabolism and oxidative stress in neonatal rat tissues from streptozotocin-induced diabetic mothers. Diabetes Metab Res Rev 2004;20:72-8.
33. Tarry-Adkins JL, Chen JH, Jones RH, Smith NH, Ozanne SE. Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life. FASEB J 2010;24:2762-71.
34. Shen JZ, Zheng XF, Kwan CY. Differential contractile actions of reactive oxygen species on rat aorta: selective activation of ATP receptor by H2O2. Life Sci 2000;66:PL291-6.
35. Demirci B, McKeown PP, Dvm UB. The bimodal regulation of vascular function by superoxide anion: role of endothelium. BMB Rep 2008;41:223-9.
36. Chamiot-Clerc P, Renaud JF, Safar ME. Pulse pressure, aortic reactivity, and endothelium dysfunction in old hypertensive rats. Hypertension 2001;37:313-21.
37. Demirci B, McKeown PP, Bayraktutan U. Blockade of angiotensin II provides additional benefits in hypertension-and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects. J Hypertens 2005;23:2219-27.
38. Gomes P, Sim S, Silva E, et al. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev 2009;2:138-45.
39. Silvia L, Miriam P, Petr K, Jaroslav K, Josef Z. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur J Pharmacol 2011;667:265-70.
40. Butler DG, Butt DA, Puskas D, Oudit GY. Angiotensin II-mediated catecholamine release during the pressor response in rats. J Endocrinol 1994;142:19-28.
41. Gordon FJ, Mark AL. Impaired baroreflex control of vascular resistance in prehypertensive Dahl S rats. Am J Physiol 1983;245:H210-7.
42. Hashmi-Hill MP, Graves JE, Sandock K, Bates JN, Robertson TP, Lewis SJ. Hemodynamic responses elicited by systemic injections of flavin adenine dinucleotide in anesthetized rats. J Cardiovasc Pharmacol 2007;50:94-102.
43. Kober T, Kig I, Weber M, Kojda G. Diethyldithiocarbamate inhibits the catalytic activity of xanthine oxidase. FEBS Lett 2003;551:99-103.
44. Shastri S, Gopalakrishnan V, Poduri R, Di Wang H. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 2002;20:1381-91.
45. Roghair RD, Miller FJ Jr, Scholz TD, Lamb FS, Segar JL. Endothelial superoxide production is altered in sheep programmed by early gestation dexamethasone exposure. Neonatology 2008;93:19-27.